Q3 2013 Holdings
Filed 2013-10-30 | 63 holdings | $67.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Idec, Inc.(BIIB) | Common | 09062X103 | $46.2M | 191,983 | 68.9% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $13.1M | 181,870 | 19.6% |
| Accuray, Inc.(ARAY) | Common | 004397105 | $5.4M | 731,943 | 8.1% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $1.5M | 23,745 | 2.3% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $94.6K | 1,504,712 | 0.1% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $81.6K | 260,699 | 0.1% |
| Celgene Corporation(CELG) | Common | 151020104 | $78.5K | 510,046 | 0.1% |
| Amgen, Inc.(AMGN) | Common | 031162100 | $46.1K | 412,143 | 0.1% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $43.1K | 371,329 | 0.1% |
| Vertex Pharmaceuticals, Inc.(VRTX) | Common | 92532F100 | $37.9K | 499,764 | 0.1% |
| Perrigo Company | Common | 714290103 | $25.0K | 202,607 | 0.0% |
| Puma Biotechnology, Inc.(PBYI) | Common | 74587V107 | $24.6K | 458,816 | 0.0% |
| Mylan, Inc. | Common | 628530107 | $18.6K | 488,209 | 0.0% |
| Shire plc | Sponsored ADR | 82481R106 | $18.5K | 154,153 | 0.0% |
| Akorn, Inc.(AKRXEUR) | Common | 009728106 | $18.4K | 935,758 | 0.0% |
| iShares Nasdaq Biotechnology ETF(IBB) | ETF | 464287556 | $17.6K | 83,940 | 0.0% |
| Warner Chilcott plc | Shares A | G94368100 | $16.3K | 713,797 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $16.1K | 421,300 | 0.0% |
| Aetna, Inc. | Common | 00817Y108 | $15.8K | 246,841 | 0.0% |
| Onyx Pharmaceuticals, Inc. | Common | 683399109 | $15.5K | 124,238 | 0.0% |
| Allergan, Inc. | Common | 018490102 | $15.1K | 166,577 | 0.0% |
| Cubist Pharmaceuticals, Inc. | Common | 229678107 | $14.4K | 226,772 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $14.1K | 296,620 | 0.0% |
| Teva Pharmaceutical Industries Ltd.(TEVA) | ADR | 881624209 | $13.4K | 354,476 | 0.0% |
| Actavis, Inc. | Common | 00507K103 | $13.2K | 91,500 | 0.0% |
| Hologic, Inc.(HOLX) | Common | 436440101 | $12.2K | 592,915 | 0.0% |
| Alere, Inc. | Common | 01449J105 | $11.3K | 369,553 | 0.0% |
| Verastem, Inc. | Common | 92337C104 | $11.0K | 884,920 | 0.0% |
| Questcor Pharmaceuticals, Inc. | Common | 74835Y101 | $9.4K | 162,328 | 0.0% |
| Ironwood Pharmaceuticals, Inc.(IRWD) | Common | 46333X108 | $9.1K | 768,050 | 0.0% |
| Amarin Corporation plc | Sponsored ADR | 023111206 | $8.8K | 1,391,723 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $8.4K | 103,841 | 0.0% |
| Ariad Pharmaceuticals, Inc. | Common | 04033A100 | $7.6K | 412,965 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $7.3K | 56,862 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $7.1K | 344,683 | 0.0% |
| Alkermes plc(ALKS) | Shares | G01767105 | $6.6K | 194,870 | 0.0% |
| Neurocrine Biosciences, Inc.(NBIX) | Common | 64125C109 | $6.5K | 570,387 | 0.0% |
| Forest Laboratories, Inc. | Common | 345838106 | $6.3K | 146,500 | 0.0% |
| Infinity Pharmaceuticals, Inc.(INFIQ) | Common | 45665G303 | $6.1K | 349,899 | 0.0% |
| UnitedHealth Group, Inc.(UNH) | Common | 91324P102 | $5.9K | 82,436 | 0.0% |
| Endo Pharmaceuticals Holdings, Inc. | Common | 29264F205 | $5.7K | 126,215 | 0.0% |
| Idexx Laboratories, Inc.(IDXX) | Common | 45168D104 | $5.6K | 56,265 | 0.0% |
| Medivation, Inc. | Common | 58501N101 | $5.5K | 92,200 | 0.0% |
| Sagent Pharmaceuticals, Inc. | Common | 786692103 | $5.5K | 270,031 | 0.0% |
| Baxter International, Inc.(BAX) | Common | 071813109 | $5.1K | 77,675 | 0.0% |
| Auxilium Pharmaceuticals, Inc. | Common | 05334D107 | $4.6K | 250,020 | 0.0% |
| Avanir Pharmaceuticals, Inc. | Common | 05348P401 | $4.1K | 960,000 | 0.0% |
| Acorda Therapeutics, Inc. | Common | 00484M106 | $3.9K | 112,881 | 0.0% |
| Merrimack Pharmaceuticals, Inc. | Common | 590328100 | $3.8K | 1,009,400 | 0.0% |
| Elan Corporation plc | ADR | 284131208 | $3.8K | 242,500 | 0.0% |